Bias and variance evaluation of QT interval correction methods

Journal of Biopharmaceutical Statistics

Volumn 18, Issue 3, 2008, Pages 427-450

  Wang, Yibin ^a   Pan, Guohua ^b   Balch, Alfred ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Conditional inferences; Fixed correction; Individual based correction; Population based correction; QT interval; QT interval correction

Indexed keywords

ARTICLE; FIXED CORRECTION; HEART BEAT; INDIVIDUAL BASED CORRECTION; INTERNAL BIAS; LINEAR REGRESSION ANALYSIS; LOGLINEAR MODEL; METHODOLOGY; POPULATION BASED CORRECTION; PRIORITY JOURNAL; QT INTERVAL; RR INTERVAL; STATISTICAL ANALYSIS; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART RATE; HUMAN; LONG QT SYNDROME; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; STATISTICS;

ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LONG QT SYNDROME; MODELS, CARDIOVASCULAR; OBSERVER VARIATION; RESEARCH DESIGN;

EID: 45849138557     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400801992988     Document Type: Article

References (12)

1. Ahnve, S. (1985). Correction of the QT interval for heart rate: review of different formulae and the use of Bazett's formula in myocardial infarction. American Heart J. 109:568-574.
2. Batchvarov, V., Malik, M. (2002). Individual patterns of QT/RR relationship. Card. Electrophysiol. Rev. 6:282-288.
3. Batchvarov, V. N., Ghuran, A., Smetana, P., Hnatkova, K., Harries, M., Dilaveris, P., Camm, A. J., Malik, M. (2002). QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am. J. Physiol. Heart Circ. Physiol. 282:H2356-H2363.
4. Dmitrienko, A., Smith, B. (2003). Repeated-measures models in the analysis of QT interval. Pharm. Sta. 2:175-190.
5. Funk-Brentano, C., Jaillon, P. (1993). Rate-corrected QT intervals: techniques and limitations. American J. Cardiology 72:17B-23B.
6. Hnatkova, K., Malik, M. (2002). "Optimum" formulae for heart rate correction of the QT interval. Pacing. Clin. Electrophysiol. 22:1683-1687.
7. ICH E14 (2005). The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs. Draft consensus guideline. Available at http://www.ich.org/.
8. Malik, M. (2001). Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J. Cardiovasc. Electrophysiol. 12:411-420.
9. Malik, M., Farbom, P., Batchvarov, V., Hnatkova, K., Camm, A. J. (2002). Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval. Heart 87:220-228.
10. Malik, M., Hnatkova, K., Batchvarov, V. (2004). Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation. Pace 27:791-800.
11. Moss, A. J. (1993). Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. American J. Cardiology 72:23B-25B.
12. Shah, A., Hajian, G. (2003). A maximum likelihood approach for establishing the QT correction factor using mixed effects model. Stat. Medicine 22:1901-1909.